Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01692951 · ClinicalTrials.gov registry record
Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 220
- Enrollment target
NCT01692951: Completed study, sponsored by The Cleveland Clinic.
NCT01692951 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 220 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01692951 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
Study Summary
This study aims to evaluate the performance of serum free fatty acids as biomarkers for the identification of lung cancer.
Primary Outcome
Biochemical analysis of serum sample was conducted by an investigator who was strictly blinded to cancer status and patient characteristics.
Interventions
- OTHER serum sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-09 |
What the finished NCT01692951 record still lists
NCT01692951 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which serum sample is the first listed.
NCT01692951 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01692951 about?
NCT01692951 is a clinical study titled "Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer". This study aims to evaluate the performance of serum free fatty acids as biomarkers for the identification of lung cancer.
What is the current status of trial NCT01692951?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2012-08. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01692951?
The interventions under investigation include: serum sample (OTHER).
Who is sponsoring clinical trial NCT01692951?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia